Borderline (suspicious) for T-cell-mediated rejection, the Banff classification's Achilles' heel

被引：0
|
作者：
van Baardwijk, Myrthe [1 ]
Wagenmakers, Anne [1 ]
van den Bosch, Thierry P. P. [1 ]
Hesselink, Dennis A. [2 ]
Loupy, Alexandre [3 ,4 ]
Kramann, Rafael [2 ,5 ]
van Huyen, Jean-Paul Duong [6 ]
Rabant, Marion [6 ]
Clahsen-van Groningen, Marian C. [1 ,5 ]
机构：
[1] Erasmus MC, Transplant Inst, Dept Pathol & Clin Bioinformat, Rotterdam, Netherlands
[2] Erasmus MC, Transplant Inst, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands
[3] Univ Paris Cite, Paris Inst Transplantat & Organ Regenerat, INSERM, PARCC, Paris, France
[4] Hop Necker Enfants Malad, Dept Transplantat, Paris, France
[5] Rhein Westfal TH Aachen, Med Fac, Dept Med 2, Aachen, Germany
[6] Necker Enfants Malad Hosp, Pathol Dept, Paris, France
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年
关键词：
D O I：
10.1093/ndt/gfae192
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection: Where Do We Stand?
    Becker, J. U.
    Chang, A.
    Nickeleit, V.
    Randhawa, P.
    Roufosse, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (09) : 2654 - 2660
  • [2] Designation of T-cell-Mediated Rejection Type IB and IIA Reflects the Type of Rejection Rather Than the Severity in the Banff Classification
    Wu, Kaiyin
    Budde, Klemens
    Schmidt, Danilo
    Neumayer, Hans-Hellmut
    Rudolph, Birgit
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 (05) : 415 - 423
  • [3] Long Term Graft Outcome after Subclinical Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection
    Han, A.
    Ko, H.
    Chung, C.
    Kim, H.
    Min, S.
    Ha, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 401 - 401
  • [4] ATP and T-cell-mediated rejection
    Castillo-Leon, Eduardo
    Dellepiane, Sergio
    Fiorina, Paolo
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2018, 23 (01) : 34 - 43
  • [5] Molecular phenotyping of T-cell-mediated rejection
    Anita S. Chong
    David L. Perkins
    [J]. Nature Reviews Nephrology, 2014, 10 : 678 - 680
  • [6] Molecular phenotyping of T-cell-mediated rejection
    Chong, Anita S.
    Perkins, David L.
    [J]. NATURE REVIEWS NEPHROLOGY, 2014, 10 (12) : 679 - 680
  • [7] IL-6 production by monocytes is associated with graft function decline in patients with borderline changes suspicious for acute T-cell-mediated rejection: a pilot study
    Desy, Olivier
    Beland, Stephanie
    Vallin, Patrice
    Riopel, Julie
    Latulippe, Eva
    Najafian, Nader
    Chandraker, Anil
    Agharazii, Mohsen
    Batal, Ibrahim
    De Serres, Sacha A.
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 (01) : 92 - 101
  • [8] Challenges Posed by the Banff Classification: Diagnosis and Treatment of Chronic active T-cell mediated Rejection
    Yamamoto, Izumi
    Kawabe, Mayuko
    Hayashi, Ayaka
    Kobayashi, Akimitsu
    Yamamoto, Hiroyasu
    Yokoo, Takashi
    [J]. NEPHRON, 2023, : 74 - 79
  • [9] Relevance of the Banff Human Organ Transplant Consensus Gene Panel for Detecting Antibody and T-Cell-Mediated Rejection of Kidney Allografts
    Giarraputo, Alessia
    Goutaudier, Valentin
    Robin, Blaise
    Angelini, Annalisa
    Sablik, Marta
    Aubert, Olivier
    Rosales, Ivy A.
    Smith, Rex N.
    Roufosse, Candice
    Adam, Benjamin
    Haas, Mark
    Colvin, Robert B.
    Lefaucheur, Carmen
    Mengel, Michael
    Zielinski, Dina
    Loupy, Alexandre
    [J]. KIDNEY INTERNATIONAL REPORTS, 2024, 9 (07): : 2290 - 2294
  • [10] Alefacept does not reduce risk of T-cell-mediated rejection
    [J]. Nature Reviews Nephrology, 2013, 9 (8) : 432 - 432
12345